THE ASAHI SHIMBUN
May 21, 2021 at 15:35 JST
The vaccine developed by Moderna Inc. arrives at Kansai International Airport on May 13. (Takuya Nishie)
Two additional vaccines for the novel coronavirus were approved by the health ministry on May 21, but only one will be widely used in the near future.
The vaccines are manufactured by Moderna Inc. and AstraZeneca Plc.
The government has signed contracts with Moderna for enough doses for 50 million people, and the vaccine is expected to be used at mass inoculation programs in Tokyo and Osaka from May 24.
The contract with AstraZeneca is for enough doses for 60 million people, but due to reports from abroad of the vaccine causing side effects in rare cases that lead to thrombosis, further studies will be conducted before deciding who it can be administered to.
The two vaccines were given the green light under a special approval procedure based on the results of clinical testing overseas, such as the vaccine jointly developed by U.S. pharmaceutical company Pfizer Inc. and German biocommerce company BioNTech, which is now being used on senior citizens.
Moderna’s vaccine must be stored at minus 20 degrees, and like Pfizer’s vaccine, uses genetic material called Messenger RNA.
AstraZeneca’s vaccine can be stored under refrigeration at around 2 to 8 degrees and uses a virus vector that delivers necessary genetic material.
Two shots will be required for effective immunization.
Study: Pfizer vaccine proves effective 12 days after 1st jab
May 19, 2021
Japan to speed up clinical trials done with other Asian countries
May 18, 2021
Experts: Speed of vaccine rollout risks 4 more emergencies
May 17, 2021
Seniors fill up slots fast for 1st mass vaccination in Tokyo, Osaka
May 17, 2021
352,000 signees, doctors union heighten calls to cancel Olympics
May 14, 2021
EXPLAINER: Why Japan has been slow to roll out vaccinations
May 14, 2021
Stories about memories of cherry blossoms solicited from readers
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series on the death of a Japanese woman that sparked a debate about criminal justice policy in the United States
A series about Japanese-Americans and their memories of World War II
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
